BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6446381)

  • 21. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination effect of piperacillin with cefoperazone on staphylococci and gram-negative bacteria.
    Daschner FD; Hoffmann P
    Arzneimittelforschung; 1982; 32(4):364-5. PubMed ID: 6213240
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillins and cephalosporins: antimicrobial and pharmacological properties.
    Wise R
    Lancet; 1982 Jul; 2(8290):140-3. PubMed ID: 6123849
    [No Abstract]   [Full Text] [Related]  

  • 25. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol].
    Knothe H; Lauer B
    Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin.
    Kamimura T; Matsumoto Y; Shigi Y; Nishida M
    Arzneimittelforschung; 1980; 30(10):1662-4. PubMed ID: 6969078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cefoperazone--activity in vitro].
    Hejzlar M; Silarová J; Pellar T; Kittnar E; Hájková L; Janatová E; Stastná L; Kotasová M; Puchmayerová M
    Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):82-6. PubMed ID: 6220824
    [No Abstract]   [Full Text] [Related]  

  • 30. Cefepime: part of the new generation.
    Rybak MJ; Palmer SM
    Am J Hosp Pharm; 1994 Feb; 51(4):459-60. PubMed ID: 8017410
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibacterial in vitro activity of fourth generation cephalosporins.
    Hancock RE; Bellido F
    J Chemother; 1996 Feb; 8 Suppl 2():31-6. PubMed ID: 8738844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Old and new cephalosporins. Pharmacologic and clinical considerations].
    Fossati C
    Clin Ter; 1985 Jan; 112(1):45-65. PubMed ID: 3893857
    [No Abstract]   [Full Text] [Related]  

  • 33. Cefroxadine (CGP-9000), an orally active cephalosporin.
    Yasuda K; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):105-10. PubMed ID: 6998373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical chemotherapy with Cefazolin: therapeutic and prophylaxic values in prenatal medicine and in gynecological surgery.
    Mazzei T; Paradiso M; Buzzoni P; Ciuffi M; Nicoletti I; Periti P
    Antibiotica; 1975; 13(2-3):57-79. PubMed ID: 1235769
    [No Abstract]   [Full Text] [Related]  

  • 35. Cefepime: the next generation?
    Sanders CC
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cephalosporins. I].
    Fossati C
    Clin Ter; 1978 Jan; 84(2):167-93. PubMed ID: 348382
    [No Abstract]   [Full Text] [Related]  

  • 38. Diastereomeric 7-alpha-ureidoacetyl cephalosporins. V. Antimicrobial activity, beta-lactamase stability and pharmacokinetics of 7-(alpha-ureido-2-amino-4-thiazolylacetyl)-cephalosporins.
    Polacek I; Starke B
    J Antibiot (Tokyo); 1980 Sep; 33(9):1031-6. PubMed ID: 6969250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cefoxitin, a new partly synthetic cephamycin antibiotic].
    Jotzoff M
    Med Welt; 1979 Jan; 30(4):147-9. PubMed ID: 310940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.